Mailed fecal testing and patient navigation versus usual care to improve rates of colorectal cancer screening and follow-up colonoscopy in rural Medicaid enrollees: a cluster-randomized controlled trial.
Mailed fecal testing and patient navigation versus usual care to improve rates of colorectal cancer screening and follow-up colonoscopy in rural Medicaid enrollees: a cluster-randomized controlled trial.
复制标题
DOI：
10.1186/s43058-022-00285-3
复制
发表时间：
2022-04-13
影响因子：
--
通讯作者：
Davis, Melinda M.
中科院分区：
文献类型：
--
作者：
Coronado, Gloria D.;Leo, Michael C.;Ramsey, Katrina;Coury, Jennifer;Petrik, Amanda F.;Patzel, Mary;Kenzie, Erin S.;Thompson, Jamie H.;Brodt, Erik;Mummadi, Raj;Elder, Nancy;Davis, Melinda M.
关键词：
Screening reduces incidence and mortality from colorectal cancer (CRC), yet US screening rates are low, particularly among Medicaid enrollees in rural communities. We describe a two-phase project, SMARTER CRC, designed to achieve the National Cancer Institute Cancer MoonshotSM objectives by reducing the burden of CRC on the US population. Specifically, SMARTER CRC aims to test the implementation, effectiveness, and maintenance of a mailed fecal test and patient navigation program to improve rates of CRC screening, follow-up colonoscopy, and referral to care in clinics serving rural Medicaid enrollees. Phase I activities in SMARTER CRC include a two-arm cluster-randomized controlled trial of a mailed fecal test and patient navigation program involving three Medicaid health plans and 30 rural primary care practices in Oregon and Idaho; the implementation of the program is supported by training and practice facilitation. Participating clinic units were randomized 1:1 into the intervention or usual care. The intervention combines (1) mailed fecal testing outreach supported by clinics, health plans, and vendors and (2) patient navigation for colonoscopy following an abnormal fecal test result. We will evaluate the effectiveness, implementation, and maintenance of the intervention and track adaptations to the intervention and to implementation strategies, using quantitative and qualitative methods. Our primary effectiveness outcome is receipt of any CRC screening within 6 months of enrollee identification. Our primary implementation outcome is health plan- and clinic-level rates of program delivery, by component (mailed FIT and patient navigation). Trial results will inform phase II activities to scale up the program through partnerships with health plans, primary care clinics, and regional and national organizations that serve rural primary care clinics; scale-up will include webinars, train-the-trainer workshops, and collaborative learning activities. This study will test the implementation, effectiveness, and scale-up of a multi-component mailed fecal testing and patient navigation program to improve CRC screening rates in rural Medicaid enrollees. Our findings may inform approaches for adapting and scaling evidence-based approaches to promote CRC screening participation in underserved populations and settings. Registered at clinicaltrial.gov (NCT04890054) and at the NCI’s Clinical Trials Reporting Program (CTRP #: NCI-2021-01032) on May 11, 2021.
登录
查看更多内容
影响因子：
--
作者：
Coury J;Miech EJ;Styer P;Petrik AF;Coates KE;Green BB;Baldwin LM;Shapiro JA;Coronado GD
通讯作者：
Coronado GD
DOI：
10.1158/1055-9965.epi-20-1793
发表时间：
2021-12
期刊：
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子：
--
作者：
通讯作者：
--
影响因子：
7.2
作者：
Coronado, Gloria D.;Schneider, Jennifer L.;Baldwin, Laura Mae
通讯作者：
Baldwin, Laura Mae
影响因子：
1.6
作者：
Coronado, Gloria D.;Sanchez, Jen;Green, Beverly
通讯作者：
Green, Beverly
影响因子：
5.7
作者：
Coronado, Gloria D.;Rivelli, Jennifer S.;Jimenez, Ricardo
通讯作者：
Jimenez, Ricardo